In this week’s episode, Procyrion CEO Eric Fain details the next steps for the startup’s ambitious plans to secure FDA approval for  Aortix, a percutaneous mechanical circulatory support (pMCS) device being developed for patients with acute decompensated heart failure (ADHF) who remain congested despite standard medical therapy (cardiorenal syndrome or CRS). Fain will talk about raising the company’s recent $57.7 million round. He’ll also share some lessons from his successful career as an executive at larger medical device companies. 

In the opening discussion, Co-Hosts Tom Salemi and Chris Newmarker talk with Santosh Iyer, CEO and Founder of Moonshot, a summer program for high school students interested in learning how the Medtech industry uses cool tech to save lives. For more information visit Moonshot.school.

Thanks for listening to the DeviceTalks Weekly Podcast. 

Subscribe to the DeviceTalks Podcast Network.

With $57m secured, CEO Fain Details Next Move for pMCS startup Procyrion; What’s Moonshot’s Mission

The DeviceTalks Podcast Network delivers news, insights and commentary from Medtech industry leaders. Our podcasts will inspire medtech professionals to create better medtech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 8 podcasts:

• AbbottTalks
• AI Meets Life Sci
• Boston Scientific Talks
• DeviceTalks Weekly
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks

Technology

Tech News

Podcasting

Gadgets

Software How-To

In this episode of AbbottTalks, Mahmood Kazemi, MD, Chief Medical Officer of Abbott’s Diabetes Care business overviews the profound advancements in diabetes management over the past decade and discusses the evolution of treatments and technological innovations that have revolutionized how individuals with diabetes approach their condition.

Further, Dr. Kazemi underscores the benefits of advancements such as the GLP-1 receptor agonists and medications that control glucose levels and offer cardiovascular and renal protection. He then elaborates on how Abbott's FreeStyle Libre continuous glucose monitoring (CGM) systems have significantly improved diabetes management. These systems provide real-time data, empowering individuals to customize their medication, diet, and activity levels with unprecedented precision. He also speaks to Abbott's ongoing and future work, including developing a state-of-the-art continuous glucose ketone monitoring (CGKM) sensor. This medical biowearable is designed to provide crucial early warning signs in Type 1 diabetes management, a significant step towards preventing dangerous complications and hospitalizations.

Looking to the future, Kazemi anticipates a wider adoption of CGM across the diabetes community, including those with type 2 diabetes, and an increase in insurer coverage.

Thank you to BMP Medical for sponsoring this episode of AbbottTalks! For more information on how BMP Medical works with medical device companies, visit www.bmpmedical.com

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Abbott’s Kazemi discusses a decade of diabetes advancements and the impact of CGM on diabetes care

In this week’s episode of the DeviceTalks Weekly Podcast, Editorial Director Tom Salemi talks about next week’s DeviceTalks Boston meeting with MedTech Innovator CEO Paul Grand.

We also hear interviews done earlier this year with speakers – Bertin Nahum of Quantum Surgical, Kurt Haggstrom of Synchron and Closing Keynote Speaker Rajit Kamal of Medtronic.

Anyone interested attending – and meeting a surprise surgical robotics guest – can register at Boston.DeviceTalks.com. Use the code DTWeekly25 to save 25% of the registration fee.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network.

It's Here! Share Your Story at DeviceTalks Boston Next Week Where You Can Meet Great Medtech Leaders

In the final episode of MedtechWOMEN Talks season one, we are joined by YJ Oh, SVP US Sales, Marketing and Commercial Operations at Edwards Lifesciences, who takes us through the intricate process of medical device commercialization. Starting with her unique entry into the medtech industry, YJ shares her comprehensive journey from sales to global marketing, emphasizing the significant role of upstream marketing in shaping product development and downstream efforts in executing commercial strategies.

In the discussion, YJ highlights the criticality of understanding market needs right from the inception of a product idea, ensuring that every development phase aligns with customer insights and real-world applicability. She provides a glimpse into the key collaborations across various departments and touches on the essential feedback mechanisms in place, ensuring devices meet the stringent requirements and expectations set forth by both regulatory bodies and the end-users, primarily physicians. Her insights extend into the strategic considerations for global market penetration, discussing how different regulatory landscapes affect the accessibility and success of medical devices across borders.

TL;DR – Key Takeaways:
- The integration of market insights from the beginning is crucial for successful medical device commercialization.
- Collaborative efforts across various functions are vital to address the comprehensive demands of product development.
- Strategic global considerations are imperative to navigate varying regulatory and market conditions effectively.

Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical!

https://aptyx.com/ 
https://catalyzehealthcare.com/ 
https://confluentmedical.com/
https://www.cretex.com/

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

Thank you for listening to MedtechWOMEN Talks!

How do I take an approved medical device to market? with YJ Oh, Edwards Lifesciences

In this episode, we visit with Rebecca Seidel, president of Medtronic’s cardiac ablation solutions group, about the future of pulsed-field ablation and what it means for the electrophysiology sector.

Host Tom Salemi also visits with biomedical researcher Jeff Karp to discuss his new book, LIT: Life Ignition Tools: Use Nature's Playbook to Energize Your Brain, Spark Ideas, and Ignite Action Kindle Edition. Use the code LIT25 to save 25% off the registration price of DeviceTalks Boston and you could win a free copy. Karp will also be at DeviceTalks Boston’s opening reception on April 30. Come meet the author and noted medtech innovator. 

Finally, we get a #DTBoston2024 speaker preview – Scott Nelson, CEO of FastWave Medical, one of two IVL companies we’ll have at the conference!

Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network

Medtronic’s Seidel Maps out Future for Electrophysiology, Pulsed-Field Ablation Portfolio

In this episode of StrykerTalks, Spencer Stiles, Group President of Orthopaedics and Spine at Stryker, discusses Stryker's latest advancements shaping the future of orthopedics and spine care, including an update on the significant role of Mako, Stryker’s pioneering robotic arm-assisted system.

Additionally, Stiles discusses the expansive reach of these innovations, emphasizing their rapid adoption across global markets, particularly in Asia, where Stryker’s advanced solutions meet diverse clinical needs and operational settings. He shares insights into how these technologies cater to the unique challenges faced in different regions, enhancing Stryker's impact on global healthcare landscapes. The conversation further explores Stryker’s strategic growth initiatives, particularly its approach to mergers and acquisitions. Stiles outlines how these moves are carefully crafted to align with Stryker’s long-term vision, ensuring that each acquisition not only expands their market presence but also complements their existing portfolio. 

Thank you to DornerWorks for sponsoring this episode. To learn more about how DornerWorks supports medical device companies, visit www.DornerWorks.com. 

Thank you for listening to the StrykerTalks Podcast.

Subscribe to the DeviceTalks Podcast Network on every major podcast platform.

With $57m secured, CEO Fain Details Next Move for pMCS startup Procyrion; What’s Moonshot’s Mission

Download our free app to listen on your phone